
Cymbeline
In William Shakespeare's "Cymbeline," King Cymbeline is furious when his only daughter, Inogen, marries Postumus, a man of low birth, instead of marrying Cymbeline's stepson, Cloten. As a result, Postumus is exiled from the kingdom and heads to Rome... There, he meets a Roman named Jaquimo and bets his wife as the stake, but what is Jaquimo's true motive? Saitama Arts Theater Grand Hall, Kitakyushu Arts Theater, Umeda Arts Theater Theater Drama City London Performance - Barbican Theater
Insights
Plot Summary
In a modern-day setting, the King of Britain is set to marry his daughter Imogen to the corrupt Cloten. Imogen, however, is secretly in love with Leonatus Posthumus, a man of lower standing. This sets in motion a chain of events involving banishment, deception, and mistaken identities, all fueled by jealousy and betrayal.
Critical Reception
Michael Almereyda's adaptation of Shakespeare's 'Cymbeline' received a mixed to negative reception. Critics were divided on the modernization of the play, with some appreciating the attempt to make the classic tale accessible to a contemporary audience, while others found the translation to a modern setting jarring and unsuccessful. The performances were also a point of contention, with some standout moments but overall a lack of cohesion.
What Reviewers Say
- The modernization of Shakespeare's 'Cymbeline' was ambitious but ultimately fell short for many critics.
- Performances were uneven, with some actors praised but the overall ensemble failing to fully connect.
- The film struggled to reconcile the play's fantastical elements with its contemporary setting.
Google audience: Google users had a generally mixed reaction to 'Cymbeline' (2012). While some appreciated the modern interpretation and certain performances, a significant portion found the film to be confusing or lacking in impact, suggesting that the adaptation did not fully succeed in its aims.
Fun Fact
The film relocates Shakespeare's tale to a contemporary New York City, with King Cymbeline reimagined as a pharmaceutical mogul.
AI-generated overview · Verify ratings on official sources